Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01455896 · ClinicalTrials.gov registry record · Phase 3
A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650
A Phase 3 study, sponsored by Intarcia Therapeutics.
- Completed
- Registry status
- Phase 3
- Development phase
- 4,156
- Enrollment target
NCT01455896: Completed Phase 3 study, sponsored by Intarcia Therapeutics.
NCT01455896 is a Phase 3 study that has completed, run by Intarcia Therapeutics. The registered enrollment target is 4,156 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (438% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01455896, a Phase 3 study, has completed, sponsored by Intarcia Therapeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 4,156 participants
- Enrollment target
Study Summary
Phase 3 study to Evaluate cardiovascular outcomes in patients with type 2 diabetes treated with ITCA 650.
Interventions
- DRUG ITCA 650
- OTHER ITCA placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,156 participants |
| Start Date | 2013-03 |
| Est. Completion | 2016-03 |
| Phase | Phase 3 |
What the finished NCT01455896 record still lists
NCT01455896 is an interventional study that assigns participants to a tested intervention. Its 4,156 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (438% higher).
The record links to 0 conditions, and to 2 interventions - of which ITCA 650 is the first listed.
NCT01455896 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01455896 about?
NCT01455896 is a clinical study titled "A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650". Phase 3 study to Evaluate cardiovascular outcomes in patients with type 2 diabetes treated with ITCA 650.
What is the current status of trial NCT01455896?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 4,156 participants. The study started on 2013-03. Estimated completion is 2016-03.
What interventions are being tested in trial NCT01455896?
The interventions under investigation include: ITCA 650 (DRUG), ITCA placebo (OTHER).
Who is sponsoring clinical trial NCT01455896?
This trial is sponsored by Intarcia Therapeutics, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01455896's enrollment target sits among peer trials
4,156 61st of 2000 higher than 1,940 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06593353 · 4,165 participants · NA
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
- NCT02693535 · 4,200 participants · Phase 2
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- NCT05969028 · 4,200 participants · NA
First Responder Airway & Compression Rate Trial
- NCT06935370 · 4,200 participants · Phase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia